Nu-Med Plus Inc (NUMD)
0.05
+0.01
(+25.00%)
USD |
OTCM |
May 31, 16:00
Nu-Med Plus Enterprise Value: 4.271M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 4.271M |
| May 30, 2024 | 3.436M |
| May 29, 2024 | 3.21M |
| May 28, 2024 | 2.646M |
| May 24, 2024 | 4.271M |
| May 23, 2024 | 4.271M |
| May 22, 2024 | 3.444M |
| May 21, 2024 | 5.272M |
| May 20, 2024 | 4.126M |
| May 17, 2024 | 4.126M |
| May 16, 2024 | 3.956M |
| May 15, 2024 | 4.114M |
| May 14, 2024 | 4.263M |
| May 13, 2024 | 5.111M |
| May 10, 2024 | 5.942M |
| May 09, 2024 | 3.925M |
| May 08, 2024 | 5.524M |
| May 07, 2024 | 5.115M |
| May 06, 2024 | 5.302M |
| May 03, 2024 | 7.195M |
| May 02, 2024 | 5.683M |
| May 01, 2024 | 5.030M |
| April 30, 2024 | 5.508M |
| April 29, 2024 | 5.176M |
| April 26, 2024 | 4.271M |
| Date | Value |
|---|---|
| April 25, 2024 | 5.650M |
| April 24, 2024 | 5.650M |
| April 23, 2024 | 5.650M |
| April 22, 2024 | 5.650M |
| April 19, 2024 | 5.650M |
| April 18, 2024 | 3.541M |
| April 17, 2024 | 3.541M |
| April 16, 2024 | 3.741M |
| April 15, 2024 | 3.741M |
| April 12, 2024 | 4.162M |
| April 11, 2024 | 4.179M |
| April 10, 2024 | 4.188M |
| April 09, 2024 | 4.188M |
| April 08, 2024 | 3.962M |
| April 05, 2024 | 4.271M |
| April 04, 2024 | 4.271M |
| April 03, 2024 | 4.271M |
| April 02, 2024 | 4.263M |
| April 01, 2024 | 5.691M |
| March 28, 2024 | 5.774M |
| March 27, 2024 | 4.937M |
| March 26, 2024 | 5.942M |
| March 25, 2024 | 4.271M |
| March 22, 2024 | 3.853M |
| March 21, 2024 | 3.853M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.7275M
Minimum
May 05 2022
75.55M
Maximum
Nov 27 2020
15.16M
Average
5.523M
Median
Nov 04 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 680.29M |
| Retractable Technologies Inc | -13.51M |
| Xtant Medical Holdings Inc | 116.30M |
| Asensus Surgical Inc | 52.33M |
| Catheter Precision Inc | 2.370M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0218M |
| Total Expenses (Quarterly) | 0.0206M |
| EPS Diluted (Quarterly) | -0.0003 |
| Earnings Yield | -2.90% |